BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Toxikon Enters Final Phase Of Building Expansion To Generate 50 Jobs Upon September Completion


10/19/2005 5:10:29 PM

BEDFORD, Mass., March 17 /PRNewswire/ -- Toxikon Corporation, a life science testing and consulting firm, has completed the first phase of a 30-45,000 square foot expansion of its laboratory facilities and will embark on the second and final phase on April 1, the company announced today.

The expansion, to be completed in September, is expected to generate approximately 50 new jobs for skilled professionals in areas of toxicology and pharmacology, analytical chemistry, biochemistry and pathology, according to Nancy DiGiulio, Vice President.

The company currently owns and occupies 75,000 square feet at 15 Wiggins Avenue in Bedford. The expansion, to a nearby building acquired in September from Sun Opta Ingredients on a lease purchase option, now provides Toxikon with a campus style setting and additional toxicology and analytical laboratories. Sun Opta will continue to occupy approximately 12,000 square feet at the 25 Wiggins Avenue expansion location.

Phase I involved space separation from Sun Opta, and designing the newly acquired space. Phase II will involve build-out and modification to the existing space and facilities, DiGiulio said. Planning, design and construction are being managed by the Richmond Group, a life sciences design build firm based in Hopkinton.

Founded in 1977, Toxikon is a privately owned contract research organization providing toxicology, pharmacology, in-vitro and analytical testing services for companies, research institutions, and government agencies, worldwide. Focused on preclinical and other early stage product and process development, Toxikon helps to assure safety, regulatory compliance, and speed-to-market for clients in biotech, pharmaceuticals, medical device, and chemical industries, worldwide. Toxikon also provides manufacturing support and test related services post approval.

Toxikon (http://www.toxikon.com/) is headquartered in Bedford, MA, and operates testing and laboratory facilities in Bedford, Jupiter, FL, and Leuven, Belgium.

Contacts: Nancy L.DiGiulio 781-275-3330 x101 nancy.digiulio@toxikon.com Anita Harris 617-354-0531 anharris@comstratgroup.com Ted Agne 781-631-3117 edagne@comstratgroup.com

Toxikon Corporation

CONTACT: Nancy L.DiGiulio of Toxikon, +1-781-275-3330 ext. 101,nancy.digiulio@toxikon.com; or Anita Harris, +1-617-354-0531,anharris@comstratgroup.com, or Ted Agne +1-781-631-3117edagne@comstratgroup.com, both of Communications Strategy Group

Web site: http//:http://www.toxikon.com/



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES